Browsing by Author "Abd-Elrahman, Khaled S."
Now showing items 1-4 of 4
-
Adipose tissue mitochondrial dysfunction and cardiometabolic diseases: On the search for novel molecular targets
Ibrahim, AlZaim; Eid, Ali H.; Abd-Elrahman, Khaled S.; El-Yazbi, Ahmed F. ( Elsevier , 2022 , Article)Cardiometabolic diseases present an escalating global health and economic burden. Such a surge is driven by epidemic prevalence rates of metabolic disorders, such as obesity and type 2 diabetes, and their associated ... -
Early metabolic impairment as a contributor to neurodegenerative disease: Mechanisms and potential pharmacological intervention
Fakih, Walaa; Zeitoun, Ralph; AlZaim, Ibrahim; Eid, Ali H.; Kobeissy, Firas; Abd-Elrahman, Khaled S.; El-Yazbi, Ahmed F.... more authors ... less authors ( Wiley , 2022 , Article Review)The metabolic syndrome comprises a family of clinical and laboratory findings, including insulin resistance, hyperglycemia, hypertriglyceridemia, low high-density lipoprotein cholesterol levels, and hypertension, in addition ... -
Editorial: Methods and application in cardiovascular and smooth muscle pharmacology: 2021
El-Yazbi, Ahmed F.; Eid, Ali H.; Zouein, Fouad A.; Abd-Elrahman, Khaled S. ( Frontiers Media S.A. , 2022 , Other)Despite significant advances in basic, translational, and clinical research tackling heart disease, cardiovascular pathologies remain among the leading causes of mortality and morbidity worldwide, being responsible for ... -
The pleiotropic effects of antithrombotic drugs in the metabolic-cardiovascular-neurodegenerative disease continuum: Impact beyond reduced clotting
Alaaeddine, Rana A.; AlZaim, Ibrahim; Hammoud, Safaa H.; Arakji, Aya; Eid, Ali H.; Abd-Elrahman, Khaled S.; El-Yazbi, Ahmed F.... more authors ... less authors ( Portland Press Ltd , 2021 , Article Review)Antithrombotic drugs are widely used for primary and secondary prevention, as well as treatment of many cardiovascular disorders. Over the past few decades, major advances in the pharmacology of these agents have been made ...